Pragma Bio

Curated by Signal

AI-powered platform for mapping the gut-immune axis for medicines

Overview

AI-powered platform for mapping the gut-immune axis for medicines. The company uses artificial intelligence and synthetic biology for mining the gut microbiome for small molecules to treat immunological disorders and advance immunotherapy.

Key facts

Founded: 2018
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

ClearHealth
Provider of an online platform offering DNA based health management solutions
Life Sciences TechnologySalt Lake City, United States
Butterfly Network
Portable ultrasound system for external ultrasound imaging
Life Sciences TechnologyGuilford, United States
Lantern Pharma
Developing drug and companion diagnostics for multi-drug resistant cancers
Life Sciences TechnologyDallas, United States

About Pragma Bio

What does Pragma Bio do?

AI-powered platform for mapping the gut-immune axis for medicines.

Where is Pragma Bio headquartered?

Pragma Bio is headquartered in San Francisco, United States.

When was Pragma Bio founded?

Pragma Bio was founded in 2018.

Which sector is Pragma Bio in?

Pragma Bio operates in Life Sciences Technology.

Who are Pragma Bio's competitors?

Companies similar to Pragma Bio include ClearHealth, Butterfly Network, and Lantern Pharma.